Yusuke Amanuma

2.1k total citations · 1 hit paper
33 papers, 876 citations indexed

About

Yusuke Amanuma is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yusuke Amanuma has authored 33 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 12 papers in Oncology. Recurrent topics in Yusuke Amanuma's work include Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (16 papers) and Alcohol Consumption and Health Effects (6 papers). Yusuke Amanuma is often cited by papers focused on Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (16 papers) and Alcohol Consumption and Health Effects (6 papers). Yusuke Amanuma collaborates with scholars based in Japan and United States. Yusuke Amanuma's co-authors include Manabu Muto, Shinya Ohashi, Osamu Kikuchi, Shin’ichi Miyamoto, Tomoyuki Gotō, Tomonari Matsuda, Tsutomu Chiba, Takahiro Horimatsu, Yukie Nakai and Atsushi Yamada and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.

In The Last Decade

Yusuke Amanuma

32 papers receiving 870 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma

2015 416 citations Shinya Ohashi, Shin’ichi Miyamoto et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yusuke Amanuma Japan	11	444	326	266	231	198	33	876
Zhe Su China	16	307 0.7×	343 1.1×	150 0.6×	314 1.4×	169 0.9×	42	857
Lie Yang China	22	720 1.6×	632 1.9×	212 0.8×	405 1.8×	180 0.9×	77	1.3k
Tingting Zhao China	17	278 0.6×	224 0.7×	89 0.3×	177 0.8×	143 0.7×	35	672
Qi Song China	19	523 1.2×	377 1.2×	101 0.4×	321 1.4×	209 1.1×	50	1.0k
Jujie Sun China	13	416 0.9×	372 1.1×	86 0.3×	208 0.9×	170 0.9×	38	785
Liuxin Cai China	10	381 0.9×	205 0.6×	146 0.5×	208 0.9×	157 0.8×	18	712
Sandra F. Martins Portugal	12	301 0.7×	223 0.7×	126 0.5×	224 1.0×	104 0.5×	39	627
Christopher D. Mann United Kingdom	12	290 0.7×	180 0.6×	230 0.9×	359 1.6×	125 0.6×	15	768
Dinghua Yang China	16	485 1.1×	387 1.2×	109 0.4×	398 1.7×	191 1.0×	41	1000
Yuanjun Jiang China	18	365 0.8×	175 0.5×	88 0.3×	117 0.5×	111 0.6×	47	734

Countries citing papers authored by Yusuke Amanuma

Since Specialization

Citations

This map shows the geographic impact of Yusuke Amanuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Amanuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Amanuma more than expected).

Fields of papers citing papers by Yusuke Amanuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Amanuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Amanuma. The network helps show where Yusuke Amanuma may publish in the future.

Co-authorship network of co-authors of Yusuke Amanuma

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Amanuma. A scholar is included among the top collaborators of Yusuke Amanuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Amanuma. Yusuke Amanuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirano, Hidekazu, Naoki Takahashi, Yusuke Amanuma, et al.. (2025). Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE). BMC Cancer. 25(1). 201–201. 1 indexed citations

Ohashi, Shinya, et al.. (2025). Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial. EClinicalMedicine. 91. 103689–103689.

Muto, Manabu, Katsuyuki Sakanaka, Shinya Ohashi, et al.. (2024). Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial.. Journal of Clinical Oncology. 42(16_suppl). 4068–4068. 1 indexed citations

Shoji, Hirokazu, Chie Kudo‐Saito, Kengo Nagashima, et al.. (2024). Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study). Journal for ImmunoTherapy of Cancer. 12(11). e010174–e010174. 2 indexed citations

Boku, Narikazu, Chie Kudo‐Saito, Hirokazu Shoji, et al.. (2023). LAG3-related factors to predict response to nivolumab monotherapy in advanced gastric cancer (WJOG10417GTR study).. Journal of Clinical Oncology. 41(4_suppl). 425–425. 2 indexed citations

Muto, Manabu, Keiko Minashi, Tomonori Yano, et al.. (2023). Expression molecular subtype as a predictor of outcomes of chemoradiotherapy for esophageal cancer.. Journal of Clinical Oncology. 41(16_suppl). 4030–4030. 1 indexed citations

Boku, Narikazu, Naoki Takahashi, Takeshi Kawakami, et al.. (2022). 1217P Profiling of myeloid cells associated with prognosis in nivolumab monotherapy for advanced gastric cancer (WJOG10417GTR study). Annals of Oncology. 33. S1105–S1105. 1 indexed citations

Chìn, Keisho, Shun Yamamoto, Masanobu Takahashi, et al.. (2022). Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3. Esophagus. 20(2). 302–308. 5 indexed citations

Mizukami, Takuro, Keiko Minashi, Hiroki Hara, et al.. (2022). An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer. Investigational New Drugs. 40(3). 614–621. 3 indexed citations

10.

Tamaoki, Masashi, Akira Yokoyama, Takahiro Horimatsu, et al.. (2021). Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy. Esophagus. 18(4). 817–824. 4 indexed citations

11.

Tamaoki, Masashi, et al.. (2019). Management for Phototoxicity after Photodynamic Therapy Using Talaporfin Sodium. Nippon Laser Igakkaishi. 40(1). 62–66. 1 indexed citations

12.

Tamaoki, Masashi, Yusuke Amanuma, Takahiro Horimatsu, Shinya Ohashi, & Manabu Muto. (2018). PS02.038: SAFETY AND EFFICACY OF REPETITIVE PHOTODYNAMIC THERAPY FOR RESIDUAL ESOPHAGEAL CANCER LESIONS AFTER INITIAL PHOTODYNAMIC THERAPY. Diseases of the Esophagus. 31(Supplement_1). 130–131. 1 indexed citations

13.

Yoshioka, Masahiro, Shinya Ohashi, Yukie Nakai, et al.. (2017). Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells. Journal of Experimental & Clinical Cancer Research. 36(1). 101–101. 25 indexed citations

14.

Aoyama, Ikuo, Shinya Ohashi, Yusuke Amanuma, et al.. (2017). Establishment of a Quick and Highly Accurate Breath Test for ALDH2 Genotyping. Clinical and Translational Gastroenterology. 8(6). e96–e96. 14 indexed citations

15.

Yamada, Atsushi, Takahiro Horimatsu, Yoshinaga Okugawa, et al.. (2015). Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Clinical Cancer Research. 21(18). 4234–4242. 131 indexed citations

16.

Amanuma, Yusuke, Shinya Ohashi, Yoshiro Itatani, et al.. (2015). Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium. Scientific Reports. 5(1). 14142–14142. 35 indexed citations

17.

Ohashi, Shinya, Shin’ichi Miyamoto, Osamu Kikuchi, et al.. (2015). Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. Gastroenterology. 149(7). 1700–1715. 416 indexed citations breakdown →

18.

Ohashi, Shinya, Osamu Kikuchi, Tomoyuki Gotō, Yusuke Amanuma, & Manabu Muto. (2015). REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 3 indexed citations

19.

Kikuchi, Osamu, Shinya Ohashi, Yukie Nakai, et al.. (2015). Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression.. PubMed. 5(8). 2431–40. 21 indexed citations

20.

Kumagai, Youichi, Masao Yagi, Junko Aida, et al.. (2011). Detailed features of palisade vessels as a marker of the esophageal mucosa revealed by magnifying endoscopy with narrow band imaging. Diseases of the Esophagus. 25(6). 484–490. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact